RCUS

RCUS R&D to Revenue

211.74%Fiscal year

Period ending:

RCUS FY R&D/Revenue%
RCUS FY R&D/Revenue3742.69%-401.00%
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

RCUS r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Arcus Biosciences Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
211.7409%
173.6434%
290.5983%
257.1429%
67.1018%
203.8462%
523.2067%
594.3493%
3,341.6844%
0%

Compare r&d to revenue

All RCUS financial metrics · RCUS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.